Amgen Inc. buy Argus
Start price
30.12.25
/
50%
€280.15
Target price
30.12.26
€305.71
Performance (%)
18.18%
Price
27.02.26
€328.55
Summary
This prediction is currently active. The prediction currently has a performance of 18.18%. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 30.12.26. The prediction end date can be changed by Argus at any time. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 3.334% | 3.334% |
| iShares Core DAX® | -0.383% | 1.093% |
| iShares Nasdaq 100 | -0.411% | -1.973% |
| iShares Nikkei 225® | 1.838% | 10.261% |
| iShares S&P 500 | -0.712% | 0.445% |
Comments by Argus for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Argus from $310.00 to $360.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat